Navigation Links
Computational biochemist uncovers a molecular clue to evolution
Date:9/10/2008

TALLAHASSEE, Fla. -- A Florida State University researcher who uses high-powered computers to map the workings of proteins has uncovered a mechanism that gives scientists a better understanding of how evolution occurs at the molecular level.

Such an understanding eventually could lead to the development of new and more effective antiparasitic drugs.

Wei Yang is an assistant professor in FSU's Department of Chemistry and Biochemistry and a faculty member in the university's Institute of molecular biophysics. Working with colleagues from FSU, Duke University and Brandeis University, he recently produced remarkable computer models of an enzyme that carries the unwieldy name of inosine monophosphate dehrydrogenase, or IMPDH for short. IMPDH is responsible for initiating certain metabolic processes in DNA and RNA, enabling the biological system to reproduce quickly.

"In creating these simulations of IMPDH, we observed something that hadn't been seen before," Yang said. "Previously, enzymes were believed to have a single 'pathway' through which they deliver catalytic agents to biological cells in order to bring about metabolic changes. But with IMPDH, we determined that there was a second pathway that also was used to cause these chemical transformations. The second pathway didn't operate as efficiently as the first one, but it was active nevertheless."

Why would an enzyme have two pathways dedicated to the same task? Yang and his colleagues believe that the slower pathway is an evolutionary vestige left over from an ancient enzyme that evolved over eons into modern-day IMPDH.

The finding is significant for several reasons, Yang said.

"First of all, this offers a rare glimpse of evolutionary processes at work on the molecular level," Yang said. "Typically when we talk about evolution, we're referring to a process of adaptation that occurs in a population of organisms over an extended period of time. Our re
'/>"/>

Contact: Wei Yang
yang@sb.fsu.edu
850-645-6884
Florida State University
Source:Eurekalert  

Page: 1 2 3

Related biology news :

1. Computational actinide chemistry: Are we there yet?
2. Computational mathematical sciences receives NSF grant for undergraduate research
3. Penn biochemist receives NIH New Innovators Award
4. Biochemists reveal details of mysterious bacterial microcompartments
5. Biochemists manipulate fruit flavor enzymes
6. St. Jude influenza survey uncovers key differences between bird flu and human flu
7. 454 Sequencing uncovers a genetic basis for different social behaviors in wasp
8. Massive microRNA scan uncovers leads to treating muscle degeneration
9. New study uncovers secrets behind butterfly wing patterns
10. UVa Health System team uncovers genes role in type 1 diabetes
11. Study uncovers clues to cystic fibrosis gene dysfunction and gastrointestinal disease

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Computational biochemist uncovers a molecular clue to evolution
Computational biochemist uncovers a molecular clue to evolution
(Date:11/9/2009)...ADELPHIA, NOVEMBER 9, 2009 A nutritionist whose ...etables to the federal Women, Infants and Children...s Agnes Higgins Award for outstanding achievement ...il Harrison, Ph.D., MNS, , a professor in the Depa...ity of California, Los Angeles School of Public He...
(Date:11/8/2009)...HEALTH EDUCATION DESIGNED FOR ADULTS WITH INTELLEC...VES , An Indiana University study involving adu...adults increased their personal health knowledge a..., Adults with ID, an internationally accepted ter...es of obesity, physical inactivity and preventable...
(Date:11/6/2009)...-dwelling ants generally live in harmony with thei...hen they run out of space in their trees of choice...s. , The research, published in the November iss...ocument that ants bore into live trees, and it reo...tween ants and plants. , Ants and certain specie...
Breaking Biology News(10 mins):March of Dimes honors Dr. Gail Harrison for outstanding work in maternal-fetal nutrition 2Indiana U. at APHA: Studies about health education for people with ID, stability balls at work 2Indiana U. at APHA: Studies about health education for people with ID, stability balls at work 3Ants are friendly to some trees, but not others 2Perrigo Confirms That its Partner Synthon Has Filed for Generic Version of Xyzal 28R 29 Solution and Announcement of Lawsuit by Sepracor UCB 49926 1Perrigo Confirms That its Partner Synthon Has Filed for Generic Version of Xyzal 28R 29 Solution and Announcement of Lawsuit by Sepracor UCB 49926 2Perrigo Confirms That its Partner Synthon Has Filed for Generic Version of Xyzal 28R 29 Solution and Announcement of Lawsuit by Sepracor UCB 49926 3Conceive Introduces New MyConceive Online Community for Women Seeking to Get Pregnant 49921 1Conceive Introduces New MyConceive Online Community for Women Seeking to Get Pregnant 49921 2Preclinical Proof of Concept Studies Published for Novavax Seasonal Influenza Virus Like Particle Vaccine 12765 1Preclinical Proof of Concept Studies Published for Novavax Seasonal Influenza Virus Like Particle Vaccine 12765 2Preclinical Proof of Concept Studies Published for Novavax Seasonal Influenza Virus Like Particle Vaccine 12765 3Preclinical Proof of Concept Studies Published for Novavax Seasonal Influenza Virus Like Particle Vaccine 12765 4
... in German . , DNA, the molecule that acts as ... life, is highly resistant against alteration by u...for its photostability presents some puzzling prob...four chemical bases that make up the DNA molecule....showing that DNA strands differ in their light sen...
...tion to the IOF World Congress on Osteoporosis 200...until October 31, 2008. , To benefit from lower ...www.iofbonehealth.org/wco/2008/homepage.html . Sp...ants from non-OECD countries and for IOF members. ...at higher rates, will be possible. , Your chance...
..., Inc. (Nasdaq:,AWRE), a leading supplier of broad...led a conference call to discuss the company,s ope...ursday, October 23, 2008, at 5:00 p.m.,Eastern Tim...st the,earnings conference call., This call is be...Investor Relations page of our website at http://...
Other Biology News:Can genetic information be controlled by light? 2Aware Announces Q3 2008 Earnings Conference Call 2
(Date:11/6/2009)...NNA, Austria, November 6 EUCODIS B...facturing, and marketing enzymes for the,chemical ...a research,agreement with Bio Sidus, the leading b... The agreement gives EUCODIS Bioscience exclusi...- to Bio Sidus, proprietary collection of,psychrop...
(Date:11/6/2009)..., Calif., Nov. 6 Intarcia Therapeu...s ITCA 650 (DUROS® continuous delivery of exe...es at the Ninth Annual Diabetes Technology Meeting...wscom.com/cgi-bin/prnh/20050301/SFTU126LOGO ) ,...Via ITCA 650 Lowers Plasma Glucose, HbA1c and Redu...
(Date:11/5/2009)...TON, Colo., Nov. 5 The endangered ...the western U.S. This rare carnivore feeds on pra... to plague and often entire population die-offs in...e (FWS) has implemented a ferret breeding program ...to their formerly native habitat. Unfortunately, ...
(Date:11/5/2009)...nce Call on Thursday, November 5, 2009 at 4:30 p.m...v. 5 /PRNewswire-FirstCall/ - OncoGenex Pharmaceut...: OGXI ) today reported unaudited financial resul...tember 30, 2009 and reviewed the Company,s highlig...wing consolidated results reflect the operations o...
Breaking Biology Technology:EUCODIS Bioscience to Explore Novel Enzymatic Activities in Antarctic Bacteria Library From Bio Sidus 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5Colorado Companies Team Up With U.S. Fish & Wildlife Service to Protect Black-Footed Ferret 2OncoGenex Reports Third Quarter 2009 Financial Results 2OncoGenex Reports Third Quarter 2009 Financial Results 3OncoGenex Reports Third Quarter 2009 Financial Results 4OncoGenex Reports Third Quarter 2009 Financial Results 5OncoGenex Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 7OncoGenex Reports Third Quarter 2009 Financial Results 8
...XEL International Corporation (Nasdaq: PRXL ), a...r, will address important industry issues at the D...Meeting, being held from March 23 - 25, 2009 in Be...rs will present on topics ranging from global bios...mbination products, and clinical process validatio...
...stCall/ - Angiotech Pharmaceuticals, Inc. (NASDAQ:...results for the fourth quarter and year ended Dece...les results in our Medical Products Business and w... new technology initiatives despite a challenging ...t and CEO of Angiotech. "Not only did we increase ...
...nd AMSTERDAM, March 5 ,Agendia, a world leader in ...appointment of Dr. Albert A. (Al) Luderer to its S...30 years of experience in in vitro medical,diagnos...ent. Currently, he,is the Chief Executive Officer ...y using innovative platform technologies to dramat...
Other Biology Technology:PAREXEL Experts to Present Leading Insights at Drug Information Association 21st Annual Euromeeting 2PAREXEL Experts to Present Leading Insights at Drug Information Association 21st Annual Euromeeting 3PAREXEL Experts to Present Leading Insights at Drug Information Association 21st Annual Euromeeting 4PAREXEL Experts to Present Leading Insights at Drug Information Association 21st Annual Euromeeting 5Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 2Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 3Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 4Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 5Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 6Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 7Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 8Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 9Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 10Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 11Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 12Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 13Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 14Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 15Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 16Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 17Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 18Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 19Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 20Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 21Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 22Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 23Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 24Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 25Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 26Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 27Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 28Agendia Appoints Seasoned Diagnostics Executive Albert A. Luderer to Supervisory Board 2
AC1 Auto System, BioChemi™ Camera from UVP
Rabbit Anti-Pendrin (H-195) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
GeneAmp AccuRT RNA PCR Kit with Controls from Applied Biosystems
Mouse Anti-Human HLA-DRbeta Monoclonal Antibody, Unconjugated, Clone DA2 from Santa Cruz Biotechnology, Inc.
Biology Products: